August IACM Bulletin.... & .... survey

[Madfingers]

Subject: IACM-Bulletin Special of 18 August 2009


> --------------------------------------------------------
> IACM-Bulletin Special of 18 August 2009
> --------------------------------------------------------
>
> * Survey on the modes of delivery of cannabinoids restarted *
>
> Due to a problem the survey on the advantages and disadvantages
> of different modes of delivery of cannabis-based drugs and
> substances had to be inactivated today for about three hours and
> restarted. The 140 patients who already answered the
> questionnaire before 18 August 2009, 7:00 pm (time in the UK) or
> 2:00 pm (time in New York), are invited to answer the
> questionnaire again. Sorry for any inconvenience.
>
> Thank you very much for your participation!
>
> People who want to support the survey are cordially invited to
> spread the word on it in the internet. There are direct links to the
> questionnaire in different languages:
>
> English: http://www.cannabis-
> med.org/limesurvey/index.php?sid=91387&lang=en
> German: http://www.cannabis-
> med.org/limesurvey/index.php?sid=91387&lang=de
> Spanish: http://www.cannabis-
> med.org/limesurvey/index.php?sid=91387&lang=es
> French (soon available): http://www.cannabis-
> med.org/limesurvey/index.php?sid=91387&lang=fr
> Dutch: http://www.cannabis-
> med.org/limesurvey/index.php?sid=91387&lang=nl
>
> Anyone who uses cannabis or other cannabinoids for medicinal
> purposes and has experience with two or more of the following
> substances or modes of delivery is invited to participate:
> - smoking of cannabis,
> - inhalation of cannabis with a vaporizer,
> - oral use of cannabis as a tea,
> - oral use of cannabis in baked goods/cannabis tincture,
> - oral use of dronabinol/Marinol (THC),
> - oral use of nabilone/Cesamet,
> - inhalation of dronabinol (THC) with a vaporizer,
> - Sativex,
> - other use.
>
> Participants remain anonymous. The survey was approved by the
> Ethics Committee of the Medical School of Hannover and is
> headed by the chairwoman of the IACM, Dr. Kirsten Mueller-
> Vahl, Professor at the Medical School of Hannover (Germany), in
> cooperation with Dr. Arno Hazekamp of the University of Leiden
> (The Netherlands), Dr. Donald Abrams, Professor at the
> University of California San Francisco (USA), Dr. Ethan Russo,
> Adjunct Associate Professor at the University of Montana
> (USA), Dr. Franjo Grotenhermen of the nova-Institut (Germany),
> Dr. Mark Ware, Assistant Professor at the McGill University,
> Montreal (Canada), Dr. Ricardo Navarrete-Varo, Malaga (Spain),
> and Dr. Rudolf Brenneisen, Professor at the University of Bern
> (Switzerland).
>
> The questionnaire is available at:
> http://www.cannabis-med.org
>